granted
on 02 Feb 2024
Last Applicant/ Owned by
Suite 300E
Washington
DC
20037
Serial Number
90730515 filed on 24th May 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations fRead More
Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the reduction of cravings for alcohol, food, nicotine, opioids, or opiates; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for the treatment of fatigue; Pharmaceutical preparations for the treatment of narcolepsy; Pharmaceutical preparations for the treatment of levodopa-induced dyskinesias in Parkinson's Disease; Pharmaceutical preparations for the treatment of viral pneumonia; Pharmaceutical preparations for the treatment of social anxiety disorder and social anxiety disorder performance-only subtype; Pharmaceutical preparations for the treatment of respiratory distress, acute respiratory distress syndrome, and inflammatory lung injury; Pharmaceutical preparations for the treatment of gastric motility and gastric emptying disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of multiple myeloma; Pharmaceutical preparations for facilitating emergence from general anesthesia; Pharmaceutical preparations for improving cognition; Pharmaceutical preparations, namely, antivirals
No 90730515
No Service/Collective Mark
No VAND-0118US3
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
02th Feb 2024 | SOU TEAS EXTENSION RECEIVED |
02th Feb 2024 | SOU EXTENSION 3 FILED |
02th Feb 2024 | SOU EXTENSION 3 GRANTED |
17th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
13th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
13th Oct 2023 | SOU EXTENSION 2 FILED |
13th Oct 2023 | SOU EXTENSION 2 GRANTED |
05th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
03rd Apr 2023 | SOU TEAS EXTENSION RECEIVED |
03rd Apr 2023 | SOU EXTENSION 1 FILED |